Delivery Order SPE2DB20D2104-SPE2DB25FMSWR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,476.56 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.84 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 25, 2025. The pharmaceutical products will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.24 to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (500-count packaging). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on April 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $47,517.99, represents a non-competitive, non-set-aside award with an ultimate completion date of September 9, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units, with a ceiling value of $1,326.38. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,611.86. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSWRDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $5,935.34 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride ER 8 MEQ tablets in quantities of 500 units. This is a firm fixed-price delivery order with no set-aside designation, awarded on June 9, 2025, with an ultimate completion date of June 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain and is registered in the System for Award Management (SAM.gov) as a major distributor of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard through flexible contract vehicles that support the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 6/9/25 |